Public health study field deals with the health of the community and aims to prevent diseases and manage them by organized actions, information sources and education efforts. It deals with physical and mental health, social well-being improvement particularly in these areas such as waste disposal, water supply, food safety or water pollution. This study field has multidisciplinary approaches such as biostatistics, health services and epidemiology. It also deals with these sub-fields: community health, behavioral health, health of economics, occupational health public policy and environmental health. Public health is important in developing world as well as developed countries.
This course focuses on the translation of basic research knowledge and developments into clinical practice in the UMC Utrecht Cancer Center.
Objectives: To gain insight into different preference valuation techniques and (pharmaco)economic evaluation methods. This module will address valuation of health states and pharmacoeconomic evaluation methods. Economic consideration play an important role in decision-making on medicines, e.g. for reimbursement purposes.
After the success of the first UK optometry summer school in 2011, we are proud to announce that the 2012 Aston University Optometry summer school will run from 28 July to 25 August 2012.
This course is designed to provide an understanding of the methods used in the evaluation of vaccines; from early human trials through to assessment of population impact and policy. It aims to address issues in high, medium and low income countries.
Objectives: To learn about available methodologies for quantitative benefit/risk assessment, to gain insight in the strengths and weaknesses of these methodologies, and to apply these methodologies in practice. Decision making on medicines informed by quantitative benefit-risk assessment may differ depending on the perspective of the decision maker and the phase of drug development.
This course aims to provide a broad perspective of the field, including a variety of subjects from views of the different stakeholders to more in depth methodological approaches, illustrated with examples and exercises.
Objectives: To enable trainees to develop an understanding of European, USA and major local and worldwide regulations and guidelines concerning pharmacovigilance. Emphasis will be placed on the problems of interpretation of pharmacovigilance regulations both pre- and post-marketing.
Objectives: To gain insight in the process of decision-making on medicines by different stakeholders. Decision making on medicines informed by quantitative benefit-risk assessment and pharmacoeconomics may differ depending on the perspective of the decision maker and the phase of drug development. This module addresses the decision-making on medicines by different stakeholders.
Objectives: To understand the role of medicines in therapeutics, health services and society; To become familiar with the life cycle of medicines and the regulatory aspects of medicines market; To review the clinical and pharmacological basis of prescribing; To understand the need to evaluate the effects of medicines from an epidemiological perspective; To understand the relevance of unbiased information to ensure the appropriate use of medicines;To discuss the need to monitor medicines prescribing process
Objectives: To understand the need to design and to carry out qualitative drug utilisation research. To be able to critically appraise qualitative drug utilisation studies (DUS). To design, to implement and to discuss small-scale audits on the quality of medicines use in hospitals and in primary health care.
This module will address in more depth the challenges (rationale , emotional and logistical) of Risk communication that have been raised in previous modules.
Objectives: To understand effect modification. To understand the principles of genetic susceptibility for drug risks